Biological impacts of imidazoline derivatives

Imidazolines, also known as dihydroimidazolines, are an important class of aromatic five-membered heterocycles that include two nitrogen atoms. Imidazolines are present in a wide range of biologically active natural and synthetic compounds. The synthesis of imidazoline-containing drugs has expanded dramatically after the findings of the imidazoline binding site (IBS) in 1984. Furthermore, many substituted imidazolines have shown potential therapeutic efficacy in the treatment of a variety of disorders, including anthelmintics, antifungal, anticancer, hypertension, and hyperglycemia, as well as Parkinson's and Alzheimer's diseases. Moreover, chiral imidazolines are extensively used as organocatalysts in the synthesis of a wide range of natural and synthetic organic molecules. This overview highlights the different pharmacological and biological activities of imidazolines derivatives.